Earlier this year, the Polk County Health Department installed a harm reduction vending machine outside of its building. The machine dispenses a number of free health and safety resources, such as ...

Humira is a prescription drug used to treat hidradenitis suppurativa (HS). Learn how the drug works, who it’s used for, and more.

Celltrion’s Yuflyma is a high concentration, citrate-free formulation of adalimumab. It is the ninth Humira biosimilar approved by the FDA and the fourth to receive interchangeability status.

Credit: Celltrion. Yuflyma, a tumor necrosis factor blocker, was approved in May 2023 as a biosimilar to Humira. Similar PK, efficacy, safety, and immunogenicity data were observed between the ...

Blue Shield of California sidesteps PBMs with new Humira biosimilar deal It’s the first time this type of model has been used to bring a Humira biosimilar to market, according to the insurer.

Blue Shield of California struck an unusual deal to buy a lower-cost version of Humira directly from a manufacturer, bypassing the giant PBMs.

UnitedHealth begins to move away from Humira, joining CVS, Express Scripts Patients who are taking Humira now will be grandfathered in.

UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs.

Teva Pharmaceuticals and Alvotech are introducing Simlandi (adalimumab-ryvk) injection in the U.S., as an interchangeable biosimilar to AbbVie’s Humira for the treatment of adult rheumatoid ...

Simlandi injection, an interchangeable biosimilar to Humira, is now available in the U.S. for the treatment of psoriatic arthritis, plaque psoriasis and other conditions, Teva Pharmaceuticals and ...

Evernorth's Accredo arm will make a Humira biosimilar available to patients with no out-of-pocket costs, the company announced on Thursday.

It’s been one year since the launch of the first adalimumab biosimilar for Humira in the United States, which was followed by eight additional adalimumab biosimilar launches. These nine FDA ...